Notice: Prescription Drug List (PDL): Triamcinolone acetonide
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt Triamcinolone acetonide.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice: Prescription Drug List (PDL): Triamcinolone acetonideHTMLEnglish publication HTML
-
Notice: Prescription Drug List (PDL): Triamcinolone acetonideHTMLFrench publication HTML
Similar records